Floatz logo

Recombinant Interleukin-12

Gestational Trophoblastic Tumor

Indiana Universityprotein_peptidePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Gestational Trophoblastic Tumor cohort.

Asset / SponsorPhaseRating
Amifostine
Gynecologic Oncology Group
Phase 3B
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 2B
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Fred Hutchinson Cancer Center
Phase 2B
MOXIFLOXACIN
OHSU Knight Cancer Institute
Phase 3B
PREDNISONE TABLETS
Fred Hutchinson Cancer Center
Phase 2B

View all 25 →

Same molecule, other indications

Recombinant Interleukin-12 is also rated in:

cutaneous melanomaDormant
BB
Indicative ·
68 / 100
View asset →
mycosis fungoidesDormant
BB
Indicative ·
64 / 100
View asset →
primary cutaneous T-cell non-Hodgkin lymphomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →